These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2118787)

  • 1. Tuberculin screening: cost-effectiveness analysis of various testing schedules.
    Schechter CB; Rose DN; Fahs MC; Silver AL
    Am J Prev Med; 1990; 6(3):167-75. PubMed ID: 2118787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis.
    Salpeter SR; Sanders GD; Salpeter EE; Owens DK
    Ann Intern Med; 1997 Dec; 127(12):1051-61. PubMed ID: 9412307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxis.
    Rose DN; Schechter CB; Fahs MC; Silver AL
    Am J Prev Med; 1988; 4(2):102-9. PubMed ID: 3134928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of the interferon-γ release assay for tuberculosis screening of hemodialysis patients.
    Kowada A
    Nephrol Dial Transplant; 2013 Mar; 28(3):682-8. PubMed ID: 23239835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
    Diel R; Nienhaus A; Loddenkemper R
    Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of preventing tuberculosis in physicians using tuberculin skin testing or a hypothetical vaccine.
    Nettleman MD; Geerdes H; Roy MC
    Arch Intern Med; 1997 May; 157(10):1121-7. PubMed ID: 9164378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Kowada A
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):857-63. PubMed ID: 26056114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
    Verma G; Chuck AW; Jacobs P
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
    Diel R; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies.
    Holmes J; Hemmett L; Garfield S
    Eur J Health Econ; 2005 Mar; 6(1):30-7. PubMed ID: 15682286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.
    Schwartzman K; Menzies D
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):780-9. PubMed ID: 10712322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis.
    Salpeter SR; Salpeter EE
    Infect Control Hosp Epidemiol; 2004 Dec; 25(12):1056-61. PubMed ID: 15636292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
    Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E
    Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers.
    del Campo MT; Fouad H; Solís-Bravo MM; Sánchez-Uriz MA; Mahíllo-Fernández I; Esteban J
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1226-34. PubMed ID: 23143360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis.
    Jones TF; Schaffner W
    Am J Respir Crit Care Med; 2001 Jul; 164(1):77-81. PubMed ID: 11435242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of screening compared to case-finding approaches to tuberculosis in long-term care facilities for the elderly.
    Marchand R; Tousignant P; Chang H
    Int J Epidemiol; 1999 Jun; 28(3):563-70. PubMed ID: 10405865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.